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INTRODUCTION 
 
Osteogenesis imperfecta (OI) is a rare genetic, 
musculoskeletal disease characterized by mutations 
in type I collagen, ultimately leading to abnormal 
collagen synthesis and assembly [1]. Although it is 
highly heterogeneous, common symptoms include 
frequent bone fractures, decreased stature, and 
progressive spinal and limb deformities. Currently 
patients are classified into eight clinical groups, 
where Type III is the most severe form compatible 
with life. To date, there is little biomechanical data 
of OI bone. Because of the limited availability and 
small size of human OI specimens, most research 
has focused on animal models. One commonly 
studied murine model of Type III OI is the 
homozygous oim B6C3Fe a/a-Col1a2oim/J strain 
(oim/oim). The goal of this study was to validate a 
system for the evaluation of oim/oim and human OI 
bone samples using micro-computed tomography 
(μCT). 
 
METHODS 
 
Animals. All animals were obtained from Jackson 
Laboratory (Bar Harbor, ME) and studies were 
performed under approval of an Institutional 
Animal Care and Use Committee (IACUC) 
protocol. Five oim/oim and five wild type (+/+) 
femora were harvested from male mice and fresh 
frozen at -70°C until μCT evaluation. Average ages 
for the oim/oim and +/+ strains at tissue dissection 
were 9 and 10 weeks, respectively. 
 
Imaging. All scans were performed using a μCT 
system developed at the Zablocki VA Medical 
Center (Milwaukee, WI) [2]. The system is 
composed of a 100.50 X-ray source (3-mm focal 
spot; Comet North America), an AI-5830-HP image 
intensifier (North American Imaging) coupled to a 
Silicon Mountain Design SMD1M-15 CCD camera 
(DALSA), and a specimen micromanipulator stage, 
all mounted on a precision rail. Femora were 
thawed, placed in 1.5-mL Eppendorf tubes filled 
with saline, mounted on the specimen stage, and 
scanned in continuous mode (33 kVp, 242 μA, 7-
frame average) at two magnification levels. 
Reconstructions were performed using a standard 
Feldkamp algorithm, with resulting voxel sizes of 
17 and 34 μm, corresponding to high and low 
magnification, respectively. 
 
Geometrical analysis. Cortical and trabecular 
regions of interest (ROIs) were isolated and 
analyzed for several structural morphometric 
parameters using ImageJ (v1.42; NIH) and 
MicroView (v2.1.2; GE Healthcare). Femoral 
length was measured using MicroView’s line tool. 
Longitudinal cortical regions were selected from the 
low magnification scans, where each ROI extended 
distally 2.5 mm from the femoral midpoint. These 
regions were analyzed for cross-sectional area 
(CSA) and cortical thickness (Ct.Th). Cylindrical 
trabecular regions were located in the high 
magnification scans just proximal to the distal 
femoral growth plate, extending proximally 1.5 mm 
with a diameter of 1 mm. After applying a local 
threshold (determined using MicroView’s auto-
threshold option), trabecular ROIs were evaluated 
for bone volume fraction (BV/TV) and trabecular 
number (Tb.N), thickness (Tb.Th), and spacing 
(Tb.Sp). 
 
Statistical analysis. Data from each genotype was 
pooled and compared for statistical significance 
using an unpaired student’s t-test. 
RESULTS AND DISCUSSION 
 
Structural data. Femoral length was not 
significantly different between the two groups. 
However, oim/oim cortical and trabecular indices 
were generally inferior to controls (Table 1) and 
agreed well with OI mouse literature [3,4]. Oim/oim 
cortical geometry was more flattened and ellipsoidal 
in appearance (Figure 1B). Mid-shaft oim/oim 
cortices showed a 16% reduction in CSA, 
suggesting decreased resistance to bending loads, as 
found in a prior study [3]. Oim/oim trabecular 
regions appeared more open in structure (Figure 
1B). This was confirmed by our findings of 
significantly reduced BV/TV and Tb.N, with a 
corresponding increase in Tb.Sp (Table 1). These 
results agree with prior findings that OI mice have 
decreased trabecular bony tissue that is also of 
reduced mechanical viability [3,4]. 
 
Extension to human OI bone. After establishing 
agreement with murine literature, we applied our 
methods to a human OI bone specimen. Pediatric OI 
patients suffer frequent fractures that require routine 
surgical intervention. Small bone fragments are 
often removed during these procedures. One such 
specimen was collected (under written consent and 
IRB approval) and fresh frozen until μCT imaging 
was conducted. The bone was scanned at 24-µm 
voxel resolution and analyzed using similar 
methods to the animal study. The wedge-shaped 
sample was composed almost exclusively of 
trabecular bone (Figure 2); thus, only applicable 
parameters were calculated. Surprisingly, the 
specimen showed increased BV/TV and Tb.N, but 
decreased Tb.Sp (Table 1) compared to healthy 
femoral head tissue [5]. One possible explanation is 
that this patient was treated with bisphosphonates, 
which have been shown to have similar effects in 
murine studies [3,4]. To our knowledge, this is the 
first application of μCT to determine morphometric 
parameters in human OI bone. 
 
 
Figure 1: Representative surface-shaded renderings of mouse 
femora from μCT data. (A) Whole femur. (B) Cortical and 
trabecular ROIs. 
 
 
Figure 2: Human OI bone sample. (A) Wedge-shaped 
specimen with dimensions 10.5 x 6.25 x 5.56 mm. (B) 
Cylindrical trabecular ROI with 3-mm diameter and 2.5-mm 
height. 
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Table 1: Summary of calculated bone parameters. 
* p < 0.06 between +/+ and oim/oim. 
† p < 0.05 between +/+ and oim/oim. 
Genotype  Morphometric Parameters 
 CSA (mm2) Ct.Th (mm) BV/TV Tb.N (mm-1) Tb.Th (mm) Tb.Sp (mm) 
Control (+/+) 0.87 ± 0.15 0.20 ± 0.03 0.25 ± 0.05 6.89 ± 1.71 0.036 ± 0.006 0.12 ± 0.04 
Oim/oim 0.73 ± 0.10* 0.19 ± 0.01 0.14 ± 0.03† 3.67 ± 1.03† 0.038 ± 0.005 0.28 ± 0.09† 
Healthy Human [5] - - 0.26 ± 0.08 1.60 ± 0.29 0.194 ± 0.033 0.64 ± 0.11 
Human OI - - 0.45 2.90 0.154 0.19 
+/+ 
OIM 
Cortical Trabecular 
A 
B 
A B 
